@FierceBiotech: The Best of FierceBiotech 2010. Report | Follow @FierceBiotech
> Japan's Otsuka is reportedly telling investors that it will use the money raised from its IPO to fund the acquisition of drug businesses. Story
> Switzerland's Covagen says it closed a Series A financing round in which CHF 6.3 million was raised. Covagen release
Special Report: FierceBiotech's Top Writers in Biotech. Report
> Quintiles and London Genetics are teaming up on a new personalized medicines initiative. Quintiles release
> Merck says it is halting studies of a single dose of the HIV drug Isentress after pondering data demonstrating its inferiority to a twice-daily dose. Story
Special Report: The Top 10 Phase III Failures of 2010. Report
> Medicago announced an extension to its partnering agreement of July 2009 with Genopole. Medicago release
And Finally... By tweaking a gene, scientists say they were able to reverse the age-related decline of mice. Story